The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
H | Systemic hormonal preparations, excl. Sex hormones and insulins | |
2
|
H01 | Pituitary and hypothalamic hormones and analogues | |
3
|
H01A | Anterior pituitary lobe hormones and analogues | |
4
|
H01AC | Somatropin and somatropin agonists | |
5
|
H01AC09 |
| Active Ingredient |
|---|
|
Lonapegsomatropin is a long-acting ‘prodrug’ of somatropin. Lonapegsomatropin consists of the parent drug, somatropin, that is transiently conjugated to a methoxypolyethylene glycol carrier (4 × 10 kDa mPEG) via a proprietary TransCon Linker. The carrier has a shielding effect that minimizes renal excretion and receptor-mediated clearance of lonapegsomatropin. |
| Document | Type | Information Source | |
|---|---|---|---|
| SKYTROFA Powder and solvent for solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| SKYTROFA Powder for solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.